NEXMAB
Dead / Abandoned — Abandoned — no statement of use filed (as of 15 Jun 2009)
What this means for you
This application is over — abandoned 15 Jun 2009. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 77076778
- Mark type
- Stylized text
- Filed
- 05 Jan 2007
- Published for opposition
- 21 Aug 2007
- Abandoned
- 15 Jun 2009
- Attorney of record
- Gretchen Stroud
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, monoclonal antibodies and fragments therefor for therapeutic purposes, namely the treatment and diagnosis of cancer, proliferative cell diseases, autoimmune diseases, infectious diseases, inflammatory diseases and genetic diseases
- Class 042 — Scientific and technological services: Pharmaceutical and biological product development for others relating to monoclonal antibodies; consultation in the field of pharmaceutical and biological product development relating to monoclonal antibodies
Owner
- Xencor, Inc., Monrovia, CA, US
- Xencor, Inc., Monrovia, CA, US
Prosecution history
- 27 Jul 2009 — REVIEW OF CORRESPONDENCE COMPLETE
- 21 Jul 2009 — PAPER RECEIVED
- 15 Jun 2009 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 15 Jun 2009 — ABANDONMENT - NO USE STATEMENT FILED
- 23 Sept 2008 — SOU EXTENSION 2 GRANTED
- 21 Sept 2008 — SOU EXTENSION 2 FILED
- 23 Sept 2008 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 21 Sept 2008 — SOU TEAS EXTENSION RECEIVED
- 17 Apr 2008 — SOU EXTENSION 1 GRANTED
- 08 Apr 2008 — SOU EXTENSION 1 FILED
- 08 Apr 2008 — SOU TEAS EXTENSION RECEIVED
- 13 Nov 2007 — NOA MAILED - SOU REQUIRED FROM APPLICANT
- 21 Aug 2007 — PUBLISHED FOR OPPOSITION
- 01 Aug 2007 — NOTICE OF PUBLICATION
- 14 May 2007 — LAW OFFICE PUBLICATION REVIEW COMPLETED